Back
Capricor Therapeutics Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
CAPR
Capricor Therapeutics
Last Price:
$13.49
Seasonality Move:
-1.81%
7 Day Trial
ALL ACCESS PASS
$
7
7 Nuclear Stocks to Buy Before They Surge
Get your report FREE today!-
The current trend is relatively stagnant and CAPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.99 | Buy |
| 20-day SMA: | 13.44 | Buy |
| 50-day SMA: | 14 | Sell |
| 200-day SMA: | 11.38 | Buy |
| 8-day EMA: | 13.16 | Buy |
| 20-day EMA: | 13.41 | Buy |
| 50-day EMA: | 13.95 | Sell |
| 200-day EMA: | 12.09 | Buy |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 49.83 | Sell |
| Chaikin Money Flow: | 418520 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Capricor Therapeutics Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 13.48 while CAPR 8-day simple moving average is 12.99, which is a Buy signal.
-
The stock price of CAPR is 13.48 while Capricor Therapeutics 20-day SMA is 13.44, which makes it a Buy.
-
Capricor Therapeutics 50-day simple moving average is 14.00 while CAPR share price is 13.48, making it a Sell technically.
-
CAPR stock price is 13.48 and Capricor Therapeutics 200-day simple moving average is 11.38, creating a Buy signal.
CAPR Technical Analysis vs Fundamental Analysis
Sell
46
Capricor Therapeutics (CAPR)
is a Sell
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a SellThe current Capricor Therapeutics [CAPR] share price is $13.48. The Score for CAPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
614.4M
Price in USD:
13.48
Share Volume:
813.9K
Capricor Therapeutics 52-Week Range
52-Week High:
23.40
52-Week Low:
3.52
Sell
46
Capricor Therapeutics (CAPR)
is a Sell
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?The Capricor Therapeutics stock price is 13.48 USD today.
-
Will CAPR stock go up or go down?Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Capricor Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is overvalued.
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 13.48 while CAPR 8-day exponential moving average is 13.16, which is a Buy signal.
-
The stock price of CAPR is 13.48 while Capricor Therapeutics 20-day EMA is 13.41, which makes it a Buy.
-
Capricor Therapeutics 50-day exponential moving average is 13.95 while CAPR share price is 13.48, making it a Sell technically.
-
CAPR stock price is 13.48 and Capricor Therapeutics 200-day simple moving average is 12.09, creating a Buy signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.57 per share, an increase this year of $0.84 per share, and an increase next year of $0.18 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
-
CAPR Moving Average Covergence Divergence (MACD) indicator is -0.35, suggesting Capricor Therapeutics is a Sell
-
Capricor Therapeutics Relative Strength Index (RSI) is 49.83, which suggest Capricor Therapeutics is oversold
-
The Bollinger Bands (25) for Capricor Therapeutics is ( - ), which suggest Capricor Therapeutics is a Buy
-
The Bollinger Bands (100) for Capricor Therapeutics is ( - ), which suggest Capricor Therapeutics is a Buy
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.